Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Grigg

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Australian and New Zealand Journal of Medicine|June 27, 2000
Deep venous thrombosis as the presenting feature in a patient with coeliac disease and homocysteinaemiaA P Grigg
Blood|June 19, 2001
Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+ thalassemiaA P Grigg
Leukemia & Lymphoma|September 24, 1999
Multiply recurrent extramedullary plasmacytomas without marrow relapse in the context of extensive chronic GVHD in a patient with myelomaA P Grigg
Leukemia & Lymphoma|November 8, 2001
2'-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphomaA P Grigg
Bone Marrow Transplantation|November 1, 1993
Approaches to the treatment of Philadelphia-positive acute lymphoblastic leukemiaA P Grigg
Internal Medicine Journal|April 3, 2008
Hepatitis B reactivation after thalidomideA P Grigg, J Sasadeusz
Leukemia & Lymphoma|March 26, 2002
Cyclosporin A for the treatment of pure red cell aplasia associated with myelodysplasiaA P Grigg, E O'Flaherty
Bone Marrow Transplantation|June 11, 2003
T-cell depletion does not necessarily compromise donor stem cell engraftment in patients receiving reduced-intensity conditioning regimensC Craddock, A P Grigg
Leukemia & Lymphoma|December 31, 1997
Optimal regimens for the mobilization and collection of peripheral blood progenitor cells from normal donorsA W Roberts, A P Grigg
Bone Marrow Transplantation|November 20, 2003
Pure red cell aplasia with the onset of graft versus host diseaseA P Grigg, S K Juneja
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Australian and New Zealand Journal of Medicine|June 27, 2000
Deep venous thrombosis as the presenting feature in a patient with coeliac disease and homocysteinaemiaA P Grigg
Blood|June 19, 2001
Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+ thalassemiaA P Grigg
Leukemia & Lymphoma|September 24, 1999
Multiply recurrent extramedullary plasmacytomas without marrow relapse in the context of extensive chronic GVHD in a patient with myelomaA P Grigg
Leukemia & Lymphoma|November 8, 2001
2'-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphomaA P Grigg
Bone Marrow Transplantation|November 1, 1993
Approaches to the treatment of Philadelphia-positive acute lymphoblastic leukemiaA P Grigg
Internal Medicine Journal|April 3, 2008
Hepatitis B reactivation after thalidomideA P Grigg, J Sasadeusz
Leukemia & Lymphoma|March 26, 2002
Cyclosporin A for the treatment of pure red cell aplasia associated with myelodysplasiaA P Grigg, E O'Flaherty
Bone Marrow Transplantation|June 11, 2003
T-cell depletion does not necessarily compromise donor stem cell engraftment in patients receiving reduced-intensity conditioning regimensC Craddock, A P Grigg
Leukemia & Lymphoma|December 31, 1997
Optimal regimens for the mobilization and collection of peripheral blood progenitor cells from normal donorsA W Roberts, A P Grigg
Bone Marrow Transplantation|November 20, 2003
Pure red cell aplasia with the onset of graft versus host diseaseA P Grigg, S K Juneja
Pageof 8